| 國立臺中教育大學 |
2022-02-07 |
傳統漆藝蒔繪在漆畫的運用－花漾・物語黃國樑創作論述
|
黃國樑; Huang, Kuo-Liang |
| 淡江大學 |
2022-02-07 |
Using Image Recognition to Process Unbalanced Data in Genetic Diseases From Biobanks
|
Hsieh, Ai-Ru;Li, Yi-Mei Aimee |
| 國家衛生研究院 |
2022-02-07 |
The influence of diabetes mellitus on the risks of end-stage kidney disease and mortality after liver transplantation
|
Lee, CY;Wu, MY;Chan, HC;Chen, TT;Hsu, LY;Wu, MS;Cherng, YG |
| 國立成功大學 |
2022-02-07 |
劇烈天氣系統與藍色噴流形成之關聯性研究
|
蘇漢宗 |
| 國家衛生研究院 |
2022-02-07 |
Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer
|
Li, MC;Coumar, MS;Lin, SY;Lin, YS;Huang, GL;Chen, CH;Lien, TW;Wu, YW;Chen, YT;Chen, CP;Huang, YC;Yeh, KC;Yang, CM;Kalita, B;Pan, SL;Hsu, TA;Yeh, TK;Chen, CT;Hsieh, HP |
| 臺大學術典藏 |
2022-02-07T03:29:02Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang Y.; Lu L.-C.; Guan Y.; Ho M.-C.; Lu S.; Spahn J.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:03Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; CHIH-HUNG HSU; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-07T03:29:03Z |
Early changes in dce-mri biomarkers may predict survival outcomes in patients with advanced hepatocellular carcinoma after sorafenib failure: Two prospective phase ii trials
|
Chen B.-B.; Lin Z.-Z.; Shao Y.-Y.; Hsu C.; CHIH-HUNG HSU; Cheng A.-L.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-02-07T03:29:04Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:04Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Chen B.-B.; Shao Y.-Y.; Lin Z.-Z.; CHIH-HUNG HSU; Cheng A.-L.; Hsu C.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Hsu C.; CHIH-HUNG HSU; Lee J.-M.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma
|
Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; CHIH-HUNG HSU; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma
|
Shao Y.-Y.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
Solving the deficit of cancer pain management skills by education programs
|
Shao Y.-Y.; Lin W.-Y.; Lin C.-P.; Lu L.-C.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:06Z |
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Lee J.-M.; Hsu C.; CHIH-HUNG HSU; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-02-07T03:29:06Z |
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy
|
Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Lin C.-C.; Chen Y.-J.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T07:48:55Z |
Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer
|
Chen J.L.-Y.; Pan C.-K.; Lin Y.-L.; Tsai C.-Y.; Huang Y.-S.; Yang W.-C.; Hsu F.-M.; SUNG-HSIN KUO; Shieh M.-J. |
| 臺大學術典藏 |
2022-02-07T07:48:56Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
SUNG-HSIN KUO; Yang S.-H.; Wei M.-F.; Lee H.-W.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-02-07T07:48:57Z |
First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias
|
Ho L.-T.; Chen J.L.-Y.; Chan H.-M.; Huang Y.-C.; Su M.-Y.; SUNG-HSIN KUO; Chang Y.-C.; Lin J.-L.; Chen W.-J.; Lee W.-J.; Lin L.-Y. |
| 臺大學術典藏 |
2022-02-07T07:48:57Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
Lin P.-H.; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; SUNG-HSIN KUO; Huang C.-S. |
| 臺大學術典藏 |
2022-02-07T07:48:58Z |
Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial
|
Yang W.-C.; Chen Y.-F.; Yang C.-C.; Wu P.-F.; Chan H.-M.; Chen J.L.-Y.; Chen G.-Y.; Cheng J.C.-H.; SUNG-HSIN KUO; Hsu F.-M. |
| 臺大學術典藏 |
2022-02-07T07:48:58Z |
Real?world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer
|
Chen J.L.-Y.; Huang C.-Y.; Huang Y.-S.; Hsu C.-Y.; Lan K.-H.; Shih I.-L.; Cheng W.-F.; Chen C.-A.; Sheu B.-C.; SUNG-HSIN KUO |
| 臺大學術典藏 |
2022-02-07T07:48:59Z |
miR-155-regulated mTOR and Toll-like receptor 5 in gastric diffuse large B-cell lymphoma
|
Huang W.-T.; SUNG-HSIN KUO; Kuo Y.-C.; Lin C.-W. |
| 臺大學術典藏 |
2022-02-07T07:48:59Z |
Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumors
|
Chen J.L.-Y.; Pan C.-K.; Huang Y.-S.; Tsai C.-Y.; Wang C.-W.; Lin Y.-L.; SUNG-HSIN KUO; Shieh M.-J. |
| 臺大學術典藏 |
2022-02-07T07:49:00Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M. |
